Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 185,491 | 183,895 | 181,499 | 159,398 | 153,459 |
| Receivables | 160,981 | 141,275 | 134,923 | 149,314 | 137,551 |
| Inventories | 141,104 | 133,099 | 137,143 | 133,934 | 127,054 |
| Income taxes - deferred | 23,832 | 25,637 | 27,253 | 26,891 | 25,990 |
| Other current assets | 33,458 | 40,321 | 29,934 | 24,034 | 21,387 |
| TOTAL | $544,866 | $524,227 | $510,752 | $493,571 | $465,441 |
| Non-Current Assets | |||||
| PPE Net | 216,927 | 216,777 | 213,868 | 210,163 | 202,748 |
| Intangibles | 243,531 | 69,209 | 50,607 | 53,044 | 54,715 |
| Other Non-Current Assets | 55,781 | 220,601 | 193,972 | 193,797 | 186,574 |
| TOTAL | $516,239 | $506,587 | $458,447 | $457,004 | $444,037 |
| Total Assets | $1,061,105 | $1,030,814 | $969,199 | $950,575 | $909,478 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 931 | 917 | 903 | 890 | 877 |
| Accounts payable and accrued liabilities | 40,614 | 36,551 | 31,032 | 29,888 | 23,334 |
| Accrued Expenses | 126,092 | 141,383 | 136,799 | 121,898 | 107,650 |
| TOTAL | $437,284 | $436,879 | $336,369 | $298,137 | $272,570 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,263 | 2,501 | 2,735 | 2,966 | 3,194 |
| Deferred Revenues | 15,647 | 15,028 | 13,635 | 12,913 | 14,119 |
| Other Non-Current Liabilities | 20,030 | 17,742 | 15,290 | 12,957 | 12,290 |
| TOTAL | $56,940 | $54,342 | $46,862 | $43,627 | $40,000 |
| Total Liabilities | $494,224 | $491,221 | $383,231 | $341,764 | $312,570 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 110,075 | 110,108 | 112,297 | 113,688 | 114,688 |
| Common Shares | 9,957 | 9,923 | 9,910 | 9,884 | 9,856 |
| Retained earnings | 1,168,069 | 1,127,326 | 1,089,316 | 1,050,809 | 1,002,152 |
| Other shareholders' equity | 24,076 | 19,769 | 23,541 | 31,025 | 24,865 |
| TOTAL | $566,881 | $539,593 | $585,968 | $608,811 | $596,908 |
| Total Liabilities And Equity | $1,061,105 | $1,030,814 | $969,199 | $950,575 | $909,478 |